Baseline characteristics and clinical presentations | Overall (n = 65) | PTRA (n = 34) | PTRAS (n = 31) | p value |
---|---|---|---|---|
Age, years | 42.5 ± 11.9 | 42.8 ± 12.4 | 42.1 ± 11.5 | 0.817 |
Male gender | 40 (61.5%) | 21 (61.8%) | 19 (61.3%) | 0.969 |
Right ABI | 1.16 (1.02, 1.28) | 1.17 (1.17, 1.17) | 1.15 (1.02, 1.28) | 0.789 |
Left ABI | 1.12 (0.93, 1.33) | 1.17 (1.17, 1.17) | 1.12 (0.93, 1.33) | 0.687 |
ESRD etiology | Â | Â | Â | Â |
 DM | 7 (10.8%) | 5 (14.7%) | 2 (6.5%) | 0.566 |
 HT | 3 (4.6%) | 1 (2.9%) | 2 (6.5%) |  |
 PKD | 2 (3.1%) | 2 (5.9%) | 0 (0.0%) |  |
 GN | 29 (44.6%) | 14 (41.2%) | 15 (48.4%) |  |
 Other | 24 (36.9%) | 12 (35.3%) | 12 (38.7%) |  |
Donor type | Â | Â | Â | Â |
 Living | 23 (35.4%) | 11 (32.4%) | 12 (38.7%) | 0.592 |
 Deceased | 42 (64.6%) | 23 (67.6%) | 19 (61.3%) 19 (61.3%) |  |
TRAS symptomatology | Â | Â | Â | Â |
 Uncontrolled HT | 11 (16.9%) | 6 (17.6%) | 5 (16.1%) | 0.987 |
  Worsening renal function | 38 (58.5%) | 20 (58.8%) | 18 (58.1%) |  |
 Uncontrolled HT and worsening renal | 11 (16.9%) | 5 (14.7%) | 6 (19.4%) |  |
 Worsening and Pulmonary edema | 1 (1.5%) | 1 (2.9%) | 0 (0.0%) |  |
 Other | 4 (6.2%) | 2 (5.9%) 2 (5.9%) | 2 (6.5%) |  |